The 3D cell culture market is projected to witness remarkable expansion, reaching an estimated USD 2.26 billion by 2030 from ...

Cancer thrives by hijacking the body's own basic survival systems, making it hard to attack tumors without collateral damage ...

Agenus, a clinical-stage immunotherapy company, and Noetik, an AI-focused multimodal biology start-up, have announced a research collaboration to develop predictive biomarkers for Agenus’s lead immuno ...

Chinese researchers have developed a novel method to efficiently engineer natural killer (NK) cells for cancer immunotherapy.

To survive in ever-changing conditions in the body, cancer cells often need to alter their metabolism. 1 This ability to adapt is especially critical for their spread to other parts of the body. “This ...

An FDA approval is setting a new benchmark for future treatment for first-line small cell lung cancer. The FDA has greenlighted Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s ...